glp-1 discovery Historical timeline of biology, receptor agonist discovery, and History of glucagon-like peptide-1 receptor

Description

CVD: Cardiovascular Disease Although several in-line GLP-1 and glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 RAs have approved indications beyond T2D and overweight/ obesity, US Pharmacopeia Drug Classification (USP DC) 2025 limits classification to categories/classes according to their primary diagnosis (e.g., antidiabetic

The half-life of a medication is the length of time that it takes your body to clear half of the medication from your system

Patients should contact their healthcare provider if they experience severe or persistent side effects, are unable to tolerate the medication, or have concerns about their response to treatment